Literature DB >> 6726714

Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup.

J P Vandenbroucke, H M Hazevoet, A Cats.   

Abstract

In a 25-year prospective followup of 209 patients with rheumatoid arthritis, median life expectancy was shortened by 7 years in males and by 3 years in females when compared with the general population. The surplus mortality was associated in decreasing order with the disease itself, associated respiratory, urogenital and general infections, and with upper gastrointestinal tract disease, mainly bleeding.

Entities:  

Mesh:

Year:  1984        PMID: 6726714

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  44 in total

Review 1.  Anti-TNF agents for rheumatoid arthritis.

Authors:  H E Seymour; A Worsley; J M Smith; S H Thomas
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

2.  Predictors of functional status in patients with early rheumatoid arthritis.

Authors:  L M Jansen; D van Schaardenburg; I E van Der Horst-Bruinsma; P D Bezemer; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 3.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

Review 4.  [Infectious pulmonary complications of rheumatic diseases].

Authors:  F Moosig; K Dalhoff
Journal:  Z Rheumatol       Date:  2009-10       Impact factor: 1.372

Review 5.  Prognostic factors of severe rheumatoid arthritis.

Authors:  R Westhovens
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

6.  Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.

Authors:  Diane Lacaille; J Antonio Avina-Zubieta; Eric C Sayre; Michal Abrahamowicz
Journal:  Ann Rheum Dis       Date:  2016-12-28       Impact factor: 19.103

7.  Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritis.

Authors:  N Inanc; H Direskeneli
Journal:  Rheumatol Int       Date:  2006-08-02       Impact factor: 2.631

8.  The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis.

Authors:  M J Al; B C Michel; F F Rutten
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

9.  Pyogenic infection and rheumatoid arthritis.

Authors:  I F Rowe; A C Deans; A C Keat
Journal:  Postgrad Med J       Date:  1987-01       Impact factor: 2.401

10.  Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.

Authors:  R Peltomaa; L Paimela; H Kautiainen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.